DA 2370 serum and synovial fluids concentrations in patients with rheumatoid arthritis.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000475:Alkenes / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000008:administration & dosage / Q000032:analysis* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D013583:Synovial Membrane / Q000378:metabolism; D013997:Time Factors
D000475:Alkenes; D000893:Anti-Inflammatory Agents; D011720:Pyrazoles